NASDAQ: HALO · Biotechnology
Over the past week, Halozyme Therapeutics (HALO) racked up about 28 mentions across Reddit, X and news, and the read is an Adanos Buy. The crowd averages 64% bullish but is deeply split: Reddit runs 75% bullish while News sits at just 54%. Wall Street is more constructive, with 7 of 9 analysts rating HALO a buy.
There is little buzz around HALO this week and little agreement on direction, which is why it reads as a Buy.
Wall Street’s 78% buy share sits next to a crowd that ranges from News at 54% to Reddit at 75%. No other tracker puts the two side by side.
Across 9 analysts the consensus is a Strong Buy: 7 buy calls against 0 sell, with an average 12-month price target of $102.11.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources only partly agree, so the read is a Buy.
Analysts sit 14 points above the crowd average of 64%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 75% bullish while News sits at 54%, a 21-point spread that single-source trackers miss.
Over the 30-day window, Halozyme Therapeutics (HALO) buzz held subdued around 27.2 while the price drifted up 3.0% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.6M shares. Updated Oct 10, 2026. Over the last 7 trading days, HALO gained 3.3%. Buzz activity in the recent week averaged 29.8 and was variable, swinging between 14.0 and 40.7. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 15 of the 21 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for HALO and 2110+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live HALO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Oct 10, 2026.
| Adanos signal | Buy |
|---|---|
| Analyst consensus | Strong Buy (7 / 2 / 0) |
| Crowd bullish (7d) | 64% |
| Avg price target | $102.11 |
| Most bullish source | Reddit, 75% |
| Most bearish source | News, 54% |
| Sentiment spread | 21 pts |
| Mentions (7d) | 28 |
| Market cap | $12.47B |
| P/E · Forward P/E | 32.1 · 11.5 |
| EPS · Beta | $3.42 · 0.9 |
| Revenue (TTM) | $1.66B · 25% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Halozyme Therapeutics (HALO) currently carries an Adanos buy signal with 93/100 conviction. The current cross-source average reads 64% bullish across 3 active sources. Those sources contribute 28 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Halozyme Therapeutics (HALO) is fairly quiet with 4 mentions over the last 7 days; the 30-day context spans 3 tracked subreddits. The 7-day tone is 75% bullish; 3-day activity momentum is rising, suggesting building attention.
The crowd reads bullish on Halozyme Therapeutics (HALO), averaging 64% bullish across 3 tracked sources over the last 7 days. The two ends of the range are Reddit at 75% bullish and News at 54%, a 21-point spread. On the professional side, 7 of 9 analysts rate HALO a buy.
Of the 9 analysts covering Halozyme Therapeutics (HALO), 7 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $102.11. That puts the street ahead of the crowd, which averages 64% bullish.
Halozyme Therapeutics (HALO)'s cross-source average is bullish at 64% bullish. All 3 tracked sources lean bullish. Reddit reads 75% bullish, X reads 64% bullish and news coverage is the most negative at 54% bullish. The combined signal points to broad buy-side pressure with 93/100 conviction.
The cross-source average is bullish for Halozyme Therapeutics (HALO) at 64% bullish. All 3 tracked sources lean bullish. The most bearish reading is news at 54% bullish. 3-day activity momentum is rising across Reddit and News. The buy signal carries 93/100 conviction.
News is the dominant discussion channel with 13 mentions (46% of total volume). X contributes 11 mentions and Reddit contributes 4 mentions. The cross-source average is bullish at 64% bullish, while reddit and news show rising 3-day activity. All 3 tracked sources lean bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. HALO's buy signal at 93/100 conviction reflects a bullish cross-source average at 64% bullish. All 3 tracked sources lean bullish. It is a research shortcut, not financial advice.
The HALO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Buy signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key